首页> 外国专利> Pharmaceutical composition, use of a sterile pharmaceutical composition, and method for improving survival in a critically ill patient

Pharmaceutical composition, use of a sterile pharmaceutical composition, and method for improving survival in a critically ill patient

机译:药物组合物,无菌药物组合物的用途以及用于改善危重患者生存率的方法

摘要

"PHARMACEUTICAL COMPOSITION, USE OF A STERILE PHARMACEUTICAL COMPOSITION, AND METHOD TO IMPROVE SURVIVAL IN A CRITICALLY SICK PATIENT". The invention relates to a method of treating and improving survival in critically ill patients and the use of certain sterile sedative pharmaceutical compositions for the manufacture of a medicament for improving the survival of such patients; in particular such use of pharmaceutical compositions comprising a free radical scavenging agent (such as propofol) and a metal ion chelating agent (such as edetate) in combination with a pharmaceutically acceptable diluent or carrier, especially such a composition comprising an emulsion of oil in water wherein the propofol is dissolved in a water immiscible solvent and emulsified with water and stabilized by a surfactant and further comprises a metal ion chelating agent (such as disodium edetate).
机译:“药物组合物,无菌药物组合物的使用以及改善重症患者生存率的方法”。本发明涉及一种治疗和改善危重患者生存的方法,以及某些无菌镇静药物组合物在制备用于改善此类患者生存的药物中的用途。特别是包含自由基清除剂(例如丙泊酚)和金属离子螯合剂(例如乙二胺四乙酸)与药学上可接受的稀释剂或载体的药物组合物的这种用途,特别是包含油在水中的乳液的组合物其中将异丙酚溶解在与水不混溶的溶剂中,并用水乳化并用表面活性剂稳定,并且还包含金属离子螯合剂(例如依地酸二钠)。

著录项

  • 公开/公告号BR0111094A

    专利类型

  • 公开/公告日2003-04-08

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20010111094

  • 发明设计人 DAVID BUELL GOODALE;

    申请日2001-05-22

  • 分类号A61K31/195;A61P43/00;

  • 国家 BR

  • 入库时间 2022-08-22 00:03:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号